GREY:TBPMQ - Post by User
Post by
SamV21on Oct 10, 2021 12:01am
223 Views
Post# 33992743
Intelgenx is doing the research and Manufacturing for Reduvo
Intelgenx is doing the research and Manufacturing for ReduvoGo to Intelgenx webpage and it says Integenx is doing all the research and testing ..I thought Tetra was doing the research and testing , not so they pay for everything they do and call it their own, once again misleading, the wording in the trials say opioid reduction NOT opioid replacement as we have been lead to believe.
Guy is a general contractor with dreams, we have paid a pile of undisclosed money to Intelgenx, as per usual he only gives ua as much information to make it sound like Tetra is working so hard on milestones, I guess the CFO might know how much we spent ,but he is gone.
Under the terms of the Agreement, Tetra is purchasing the worldwide Adversa® technology rights as it relates to its PPP-002 (Dronabinol) drug product candidate for three undisclosed milestone payments: 45% to be paid on November 15, 2020; 45% to be paid on March 1, 2021, and a final payment of 10% upon successful technology transfer. In addition, Tetra will pay IntelGenx a low single digit royalty on future net sales of Dronabinol mucoadhesive tablets.The only one retiring here will be Guy the people that invested 3 and 4 years ago while the market went up 30% and Tetra went down over 80% will be left high and dry . Thanks for nothing.